ArticleComputational and structural biotechnology journal2025
GL4SDA: Predicting snoRNA-disease associations using GNNs and LLM embeddings.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Dual Cross-Attention Network for Hierarchical Feature Fusion in Protein-Protein Interaction Prediction.Computational and structural biotechnology journal · 2026Article
- Generative Chemistry Platform for Small Molecules Targeting RNA: A Case Study for Chemical Optimization.Computational and structural biotechnology journal · 2026Article
- CGSDA: inferring snoRNA-disease associations via ChebNetII and GatedGCN.Frontiers in genetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small nucleolar RNAs (snoRNAs) play essential roles in various cellular processes, and their associations with diseases are increasingly recognized. Identifying these snoRNA-disease relationships is critical for advancing our understanding of their functional roles and potential therapeutic implications. This work presents a novel approach, called GL4SDA, to predict snoRNA-disease associations using Graph Neural Networks (GNN) and Large Language Models. Our methodology leverages the unique strengths of heterogeneous graph structures to model complex biological interactions. Differently from existing methods, we define a set of features able to capture deeper information content related to the inner attributes of both snoRNAs and diseases and design a GNN model based on highly performing layers, which can maximize results on this representation. We consider snoRNA secondary structures and disease embeddings derived from large language models to obtain snoRNAs and disease node features, respectively. By combining structural features of snoRNAs with rich semantic embeddings of diseases, we construct a feature-rich graph representation that improves the predictive performance of our model. We evaluate our approach using different architectures that exploit the capabilities of many graph convolutional layers and compare the results with three other state-of-the-art graph-based predictors. GL4SDA demonstrates improved scores in link prediction tasks and demonstrates its potential implication as a tool for exploring snoRNA-disease relationships. We also validate our findings through biological case studies about cancer diseases, highlighting the practical application of our method in real-world scenarios and obtaining the most important snoRNA features using explainable artificial intelligence methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.